PLCG1 and hepatocellular carcinoma: To further assess the effects of the PRGs in HCC, a five-PRG risk model, including GSDME, NOD1, PLCG1, NLRP6 and NLRC4, was identified to be greatly linked with the overall survival (OS) of HCC patients.